Physician profile
Kevin A Smith
NPI 1386630895
$2,236.99
in general payments reported to CMS, 2019-2025
21 companies · $447 in 2025
The $447 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $585 · 2020: $208 · 2021: $281 · 2022: $249 · 2023: $252 · 2024: $215 · 2025: $447.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $914.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $914.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $656.90 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Corcept Therapeutics | $280.25 | 2024-2025 | Korlym |
| Janssen Pharmaceuticals, INC | $234.18 | 2019-2020 | |
| Lilly USA, LLC | $222.29 | 2019-2024 | Mounjaro, Emgality, Jardiance |
| Abbott Laboratories | $167.72 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $148.17 | 2022-2023 | |
| Stimwave Technologies Incorporated | $127.25 | 2019 | |
| Eisai INC. | $55.77 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $47.39 | 2020-2021 | |
| Philips North America LLC | $43.48 | 2019-2023 | |
| Sanofi-Aventis U.S. LLC | $35.00 | 2019-2021 | |
| Amgen INC. | $31.30 | 2025 | Krystexxa |
| Dexcom, INC. | $28.26 | 2024 | Dexcom G6 Transmitter |
| Glaxosmithkline, LLC. | $23.85 | 2023 | Rotarix, Shingrix |
| Biohaven Pharmaceutical Holding Company LTD. | $23.63 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $22.19 | 2022 | |
| Exact Sciences Corporation | $20.97 | 2025 | Cologuard Collection Kit |
| Lucid Diagnostics INC. | $19.64 | 2023 | |
| Biohaven Pharmaceuticals, INC. | $17.57 | 2021 | |
| Hologic Sales and Service, LLC | $17.41 | 2023 | Thinprep 2000 Processor |
| Novo Nordisk INC | $13.77 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.